These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1829879)

  • 41. Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients.
    Verhagen C; De Pauw BE; Williams KJ; Du Bois W
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):178-82. PubMed ID: 3134208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.
    Ramphal R; Bolger M; Oblon DJ; Sherertz RJ; Malone JD; Rand KH; Gilliom M; Shands JW; Kramer BS
    Antimicrob Agents Chemother; 1992 May; 36(5):1062-7. PubMed ID: 1510394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer.
    Viscoli C; Moroni C; Boni L; Bruzzi P; Comelli A; Dini G; Fabbri A; Secondo V; Terragna A
    Rev Infect Dis; 1991; 13(3):397-404. PubMed ID: 1866542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
    Cordonnier C; Herbrecht R; Pico JL; Gardembas M; Delmer A; Delain M; Moreau P; Ladeb S; Nalet V; Rollin C; Gres JJ
    Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin.
    Greenberg RN
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2392-7. PubMed ID: 2150908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy.
    Hung KC; Chiu HH; Tseng YC; Wang JH; Lin HC; Tsai FJ; Peng CT
    J Microbiol Immunol Infect; 2003 Dec; 36(4):254-9. PubMed ID: 14723254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
    Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR
    Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
    Chuang YY; Hung IJ; Yang CP; Jaing TH; Lin TY; Huang YC
    Pediatr Infect Dis J; 2002 Mar; 21(3):203-9. PubMed ID: 12005083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients.
    Eggimann P; Glauser MP; Aoun M; Meunier F; Calandra T
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():151-63. PubMed ID: 8150759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia.
    Santhosh-Kumar CR; Ajarim DS; Harakati MS; al Momen AK; al Mohareb F; Zeitany RG
    J Infect; 1992 Jul; 25(1):11-9. PubMed ID: 1365011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
    Klastersky J; Glauser MP; Schimpff SC; Zinner SH; Gaya H
    Antimicrob Agents Chemother; 1986 Feb; 29(2):263-70. PubMed ID: 3521475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia.
    Rubin M; Hathorn JW; Marshall D; Gress J; Steinberg SM; Pizzo PA
    Ann Intern Med; 1988 Jan; 108(1):30-5. PubMed ID: 3337513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A clinical trial on efficacy and safety of teicoplanin in combination with beta-lactams and aminoglycosides in the treatment of severe sepsis of patients undergoing allogeneic/autologous bone marrow transplantation.
    Lang E; Schmid J; Fauser AA
    Br J Haematol; 1990 Dec; 76 Suppl 2():14-8. PubMed ID: 2149045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).
    Schaefer F; Klaus G; Müller-Wiefel DE; Mehls O
    J Am Soc Nephrol; 1999 Jan; 10(1):136-45. PubMed ID: 9890319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
    Glauser MP; Brennscheidt U; Cornely O; Grigg A; Figuera A; Keyserling C; Trostmann U; Welling L; Tack K
    Clin Microbiol Infect; 2002 Jan; 8(1):14-25. PubMed ID: 11906496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ceftazidime as first-line therapy for fever in acute leukaemia.
    Donnelly JP; Marcus RE; Goldman JM; Cohen J; Worsley AM; Catovsky D; Darrell JH; Want SV; Galton DA
    J Infect; 1985 Nov; 11(3):205-15. PubMed ID: 3910730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Empiric monotherapy in neutropenia: a realistic goal?
    Del Favero A; Bucaneve G; Menichetti F
    Scand J Infect Dis Suppl; 1995; 96():34-7. PubMed ID: 7652501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
    Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support.
    Egerer G; Goldschmidt H; Streich N; Ehrhard I; Sonntag HG; Haas R
    Support Care Cancer; 1999 Sep; 7(5):336-42. PubMed ID: 10483819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.